Artiva Biotherapeutics, Inc.: CEO Aslan Fred sold 61,696 shares

What happened

• Aslan Fred, CEO, sold 61,696 shares at $6.84 per share on Oct 5, 2026, for $421,828, according to the Form 4 filed Oct 6, 2026.

Key details

• Transaction date and price: Oct 5, 2026 at $6.84 per share (transaction code S).
• Amount disposed: 61,696 shares for $421,828.
• Shares owned after the transaction: not reported in the Form 4.
• Footnote F1: the filing states the issuer has a "sell-to-cover" policy and that these sales represent the number of shares required to be sold to cover tax withholding obligations in connection with the vesting and release of restricted stock units; such sales were automatic and not at the discretion of the reporting person.
• Filing date and timeliness: Form 4 filed on Oct 6, 2026; filing is not indicated as late.

Why it may matter

• This was a sale reported as a sell-to-cover for tax withholding related to vested restricted stock units, not an option exercise or a gift.
• The filing does not show why the insider traded or why the company acted.